With all due respect, I think you are grasping at straws. I believe Bavi + chemo is, as King said, shelved and the focus going forward is I/O. It joins Cotara on the shelf IMO. Maybe you have some basis for thinking they could take it to the FDA, but the reality is no one has ever gotten approval based on a terminated trial, if I am reading some of the knowledgeable posters correctly.